Welcome to the Institutional Repository CONACYT


Bienvenido al Repositorio Nacional de México

Este es el medio de Acceso Abierto que el CONACyT ha habilitado para la consulta y el depósito de los recursos de información científica, tecnológica y de innovación (RIACTIs). El Repositorio Nacional busca poner a disposición del público en general los recursos de información derivados de proyectos de investigación científica, tecnológica y la innovación para facilitar su consulta, uso y reúso.

Browsing by Title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 3605 to 3624 of 6272


Issue DateTitlePublication Type/ Resource TypeAuthor(s)Submit Date
2020Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding DomainArtículoXiaojing Chi.; Xiuying Liu.; Conghui Wang.; Xinhui Zhang.; Lili Ren.; Qi Jin.; Jianwei Wang.; Wei Yang.-
2020Hundreds of severe pediatric COVID-19 infections in Wuhan prior to the lockdownArtículoDu, Zhanwei.; Nugent, Ciara.; Cowling, Benjamin J.; Meyers, Lauren Ancel.-
2020Hundreds of severe pediatric COVID-19 infections in Wuhan prior to the lockdownPreimpresoZhanwei Du; Ciara Nugent; Benjamin J Cowling; Lauren Ancel Meyers-
2020Hydrogen Peroxide Vapor sterilization of N95 respirators for reuseArtículoPatrick Kenney.; Benjamin K Chan.; Kaitlyn Kortright.; Margaret Cintron.; Nancy Havill.; Mark Russi.; Jaqueline Epright.; Lorraine Lee.; Thomas Balcezak.; Richard Martinello.-
2020Hydroxychloroquine (HCQ): an observational cohort study in primary and secondary prevention of pneumonia in an at-risk populationArtículoAlain Vanasse.; Josiane Courteau.; Yohann Chiu.; Andre Cantin.; Richard Leduc.-
2020Hydroxychloroquine and covid-19ArtículoSinha Neeraj.; Balayla Galit.-
2020Hydroxychloroquine as an Aerosol Might Markedly Reduce and Even Prevent Severe Clinical Symptoms after SARS-CoV-2 InfectionArtículoKlimke Ansgar.; Hefner Gudrun.; Will Bianca.; Voss Ursula.-
2020Hydroxychloroquine for treatment of SARS-CoV-2 infection? Improving our confidence in a model-based approach to dose selection.ArtículoSL Arnold.; F Buckner.-
2020Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trialArtículoWei Tang.; Zhujun Cao.; Mingfeng Han.; Zhengyan Wang.; Junwen Chen.; Wenjin Sun.; Yaojie Wu.; Wei Xiao.; Shengyong Liu.; Erzhen Chen.; Wei Chen.; Xiongbiao Wang.; Jiuyong Yang.; Jun Lin.; Qingxia Zhao.; Youqin Yan.; Zhibin Xie.; Dan Li.; Yaofeng Yang.; Leshan Liu.; Jieming Qu.; Guang Ning.; Guochao Shi.; Qing Xie.-
2020Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemicArtículoScuccimarri Rosie.; Sutton Evelyn.; Fitzcharles Mary-Ann.-
2020Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysisArtículoLippi Giuseppe.; Wong Johnny.; Henry Brandon Michael.-
2020Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational studyArtículoZhenhua Zeng.; Tong Sha.; Yuan Zhang.; Feng Wu.; Hongbin Hu.; Haijun Li.; Jiafa Han.; Wenhong Song.; Qiaobing Huang.; Zhongqing Chen.-
2020I May Not Have Symptoms, but COVID-19 Is a Huge HeadachePreimpresoCranford, S-
2019Identification and characterization of a human coronavirus 229E nonstructural protein 8-associated RNA 3=-terminal adenylyltransferase activityPreimpresoTvarogová, J; Madhugiri, R; Bylapudi, G; Ferguson, L; Karl, N; Ziebuhr, J-
2020Identification of a novel linear B-cell epitope on the nucleocapsid protein of porcine deltacoronavirusPreimpresoFu, J; Chen, R; Hu, J; Qu, H; Zhao, Y; Cao, S; Wen, X; Wen, Y; Wu, R; Zhao, Q; Ma, X; Huang, X-
2020Identification of a super-spreading chain of transmission associated with COVID-19ArtículoHu Ke.; Zhao Yang.; Wang Mengmei.; Zeng Qiqi.; Wang Xiaorui.; Wang Ming.; Zheng Zhishui.; Li Xiaochen.; Zhang Yunting.; Wang Tao.; Zeng Shaolin.; Jiang Yan.; Liu Dan.; Yu Wenzhen.; Hu Fang.; Qin Hongyu.; Hao Jingcan.; Yuan Jian.; Shang Rui.; Jiang Meng.; Ding Xi.; Zhang Binghong.; Shi Bingyin.; Zhang Chengsheng.-
2020Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugsArtículoSangeun Jeon.; Meehyun Ko.; Jihye Lee.; Inhee Choi.; Soo Young Byun.; Soonju Park.; David Shum.; Seungtaek Kim.-
2020Identification of coronavirus isolated from a patient in Korea with covid-19PreimpresoKim, J; Chung, Y; Jo, H; Lee, N; Kim, M; Woo, S; Park, S; Kim, J; Kim, H; Han, M-
2019Identification of diverse bat alphacoronaviruses and betacoronaviruses in china provides new insights into the evolution and origin of coronavirus-related diseasesPreimpresoHan, Y; Du, J; Su, H; Zhang, J; Zhu, G; Zhang, S; Wu, Z; Jin, Q-
2019Identification of pantropic canine coronavirus in a wolf (Canis lupus italicus) in ItalyPreimpresoAlfano, F; Dowgier, G; Valentino, M; Galiero, G; Tinelli, A; Decaro, N; Fusco, G-